| Literature DB >> 27777642 |
Marek L Kowalski1, Ignacio Ansotegui2, Werner Aberer3, Mona Al-Ahmad4, Mubeccel Akdis5, Barbara K Ballmer-Weber6, Kirsten Beyer7, Miguel Blanca8, Simon Brown9, Chaweewan Bunnag10, Arnaldo Capriles Hulett11, Mariana Castells12, Hiok Hee Chng13, Frederic De Blay14, Motohiro Ebisawa15, Stanley Fineman16, David B K Golden17, Tari Haahtela18, Michael Kaliner19, Connie Katelaris20, Bee Wah Lee21, Joanna Makowska22, Ulrich Muller23, Joaquim Mullol24, John Oppenheimer25, Hae-Sim Park26, James Parkerson27, Giovanni Passalacqua28, Ruby Pawankar29, Harald Renz30, Franziska Rueff31, Mario Sanchez-Borges32, Joaquin Sastre33, Glenis Scadding34, Scott Sicherer35, Pongsakorn Tantilipikorn10, James Tracy36, Vera van Kempen37, Barbara Bohle38, G Walter Canonica39, Luis Caraballo40, Maximiliano Gomez41, Komei Ito42, Erika Jensen-Jarolim43, Mark Larche44, Giovanni Melioli45, Lars K Poulsen46, Rudolf Valenta47, Torsten Zuberbier48.
Abstract
One of the major concerns in the practice of allergy is related to the safety of procedures for the diagnosis and treatment of allergic disease. Management (diagnosis and treatment) of hypersensitivity disorders involves often intentional exposure to potentially allergenic substances (during skin testing), deliberate induction in the office of allergic symptoms to offending compounds (provocation tests) or intentional application of potentially dangerous substances (allergy vaccine) to sensitized patients. These situations may be associated with a significant risk of unwanted, excessive or even dangerous reactions, which in many instances cannot be completely avoided. However, adverse reactions can be minimized or even avoided if a physician is fully aware of potential risk and is prepared to appropriately handle the situation. Information on the risk of diagnostic and therapeutic procedures in allergic diseases has been accumulated in the medical literature for decades; however, except for allergen specific immunotherapy, it has never been presented in a systematic fashion. Up to now no single document addressed the risk of the most commonly used medical procedures in the allergy office nor attempted to present general requirements necessary to assure the safety of these procedures. Following review of available literature a group of allergy experts within the World Allergy Organization (WAO), representing various continents and areas of allergy expertise, presents this report on risk associated with diagnostic and therapeutic procedures in allergology and proposes a consensus on safety requirements for performing procedures in allergy offices. Optimal safety measures including appropriate location, type and required time of supervision, availability of safety equipment, access to specialized emergency services, etc. for various procedures have been recommended. This document should be useful for allergists with already established practices and experience as well as to other specialists taking care of patients with allergies.Entities:
Year: 2016 PMID: 27777642 PMCID: PMC5062928 DOI: 10.1186/s40413-016-0122-3
Source DB: PubMed Journal: World Allergy Organ J ISSN: 1939-4551 Impact factor: 4.084